Janssen-Cilag S.p.A.
- A01 - Preparados estomatológicos
- DAKTARIN oral gel 2%
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PARIET gastro-resistant tablet 10 mg
- PARIET gastro-resistant tablet 20 mg
- A03 - Agentes contra padecimientos funcionales del estómago e intestino
- MOTILIUM effervescent granules 10 mg
- MOTILIUM film-coated tablet 10 mg
- MOTILIUM oral suspension 1 mg/ml
- B03 - Preparados antianémicos
- EPREX solution for injection 1 000 IU/0.5 ml
- EPREX solution for injection 10 000 IU/1 ml
- EPREX solution for injection 2 000 IU/0.5 ml
- EPREX solution for injection 20 000 IU/0.5 ml
- EPREX solution for injection 3 000 IU/0.3 ml
- EPREX solution for injection 30 000 IU/0.75 ml
- EPREX solution for injection 4 000 IU/0.4 ml
- EPREX solution for injection 4 000 IU/1 ml
- EPREX solution for injection 40 000 IU/1 ml
- EPREX solution for injection 5 000 IU/0.5 ml
- EPREX solution for injection 6 000 IU/0.6 ml
- EPREX solution for injection 8 000 IU/0.8 ml
- G01 - Antiinfecciosos y antisépticos ginecológicos
- DAKTARIN DERMATOLOGICO cream 2%
- DAKTARIN DERMATOLOGICO cutaneous powder 2%
- DAKTARIN DERMATOLOGICO cutaneous solution 2%
- DAKTARIN DERMATOLOGICO cutaneous spray, powder 2%
- DAKTARIN vaginal capsule, soft 400 mg
- DAKTARIN vaginal cream 2%
- G04 - Urológicos
- LYRINEL prolonged-release tablet 10 mg
- LYRINEL prolonged-release tablet 5 mg
- J02 - Antimicóticos de uso sistémico
- SPORANOX capsule, hard 100 mg
- SPORANOX concentrate for solution for infusion
- SPORANOX oral solution 10 mg/ml
- J05 - Antivirales de uso sistémico
- OLYSIO capsule, hard 150 mg
- L01 - Antineoplásicos
- LEUSTATIN solution for injection 10 mg/10 ml
- N02 - Analgésicos
- DUROGESIC transdermal patch 100 µg/h
- DUROGESIC transdermal patch 12 µg/h
- DUROGESIC transdermal patch 25 µg/h
- DUROGESIC transdermal patch 50 µg/h
- DUROGESIC transdermal patch 75 µg/h
- JURNISTA prolonged-release tablet 16 mg
- JURNISTA prolonged-release tablet 32 mg
- JURNISTA prolonged-release tablet 4 mg
- JURNISTA prolonged-release tablet 64 mg
- JURNISTA prolonged-release tablet 8 mg
- N03 - Antiepilépticos
- TOPAMAX film-coated tablet 100 mg
- TOPAMAX film-coated tablet 200 mg
- TOPAMAX film-coated tablet 25 mg
- TOPAMAX film-coated tablet 50 mg
- TOPAMAX SPRINKLE capsule, hard 15 mg
- TOPAMAX SPRINKLE capsule, hard 25 mg
- N05 - Psicolépticos
- HALDOL DECANOAS solution for injection 150 mg/3 ml
- HALDOL DECANOAS solution for injection 50 mg/1 ml
- HALDOL oral solution 2 mg/ml
- HALDOL solution for injection 5 mg/1 ml
- HALDOL tablet 1 mg
- HALDOL tablet 5 mg
- RISPERDAL DEPOT powder and solvent for suspension for injection 25 mg+2 ml
- RISPERDAL DEPOT powder and solvent for suspension for injection 37.5 mg+2 ml
- RISPERDAL DEPOT powder and solvent for suspension for injection 50 mg+2 ml
- RISPERDAL film-coated tablet 1 mg
- RISPERDAL film-coated tablet 2 mg
- RISPERDAL film-coated tablet 3 mg
- RISPERDAL film-coated tablet 4 mg
- RISPERDAL oral drops, solution 1 mg/ml
- N06 - Psicoanalépticos
- REMINYL oral solution 4 mg/ml
- REMINYL prolonged-release capsule, hard 16 mg
- REMINYL prolonged-release capsule, hard 24 mg
- REMINYL prolonged-release capsule, hard 8 mg
- REMINYL STARTER PACK prolonged-release capsule, hard 8 mg - 16 mg
- N07 - Otros fármacos activos sobre el sistema nervioso
- STUGERON capsule, hard 75 mg
- STUGERON oral drops, solution 75 mg/ml
- STUGERON tablet 25 mg
- P02 - Antihelmínticos
- VERMOX oral suspension 20 mg/ml
- VERMOX tablet 100 mg
- VERMOX tablet 500 mg